明基医院招股结束 孖展认购额录得3.68亿港元 超购3.7倍

Group 1 - The core viewpoint of the news is that Mingji Hospital has successfully completed its IPO subscription, with significant oversubscription and plans to list on December 22 [1] - Mingji Hospital plans to issue 67 million shares at a price range of HKD 9.34 to HKD 11.68, aiming to raise up to HKD 782 million [1] - The funds raised will be allocated as follows: approximately 74.3% for expansion and upgrading of existing hospitals, about 16% for potential investments and acquisitions, around 8% for upgrading to a "smart hospital," and about 1.8% for working capital and general corporate purposes [1] Group 2 - Mingji Hospital is a private for-profit general hospital group in mainland China, operating two hospitals: Nanjing Mingji Hospital and Suzhou Mingji Hospital [2] - According to Frost & Sullivan, Mingji Hospital is the largest private for-profit general hospital group in East China by total revenue in 2024, holding a market share of 1.0% in the region [2] - The company ranks seventh among private for-profit general hospital groups nationwide in China, with a market share of 0.4%, and it ranks first in bed revenue among all private for-profit general hospital groups in mainland China for 2024 [2]